(Q46472362)

English

Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy

scientific article published in January 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Isabelle Ragueneau-Majlessi

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Rene H Levy

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Martin Brodie

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

David Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Jaymin Shah

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

John S Grundy

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

44

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

517-523

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mechanistic approach to antiepileptic drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically significant pharmacokinetic drug interactions with benzodiazepines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of the newer antiepileptic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of felbamate on valproic acid disposition

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology and therapeutic drug monitoring of zonisamide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sodium valproate acutely inhibits lamotrigine metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15871637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200544050-00005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15871637

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46472362&oldid=2207889245"